- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Conse…
Number of the records: 1  

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)

  1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) / Drgona L. ... [et al.].
    In: Onkológia. -- ISSN 1336-8176. -- Roč. 13, č. 1 (2018), s. 73.
    choroby infekčné * terapia biologická * terapia molekulárne cielená * protilátky monoklonálne * abstrakt v angličtine
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.